Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Blueprint for Access to Innovative Healthcare Episode 2: Screening

By: 3BL Media

June 17, 2021 at 06:00 AM EDT

SOURCE: Takeda

DESCRIPTION:

Takeda’s flagship Access to Medicines initiative, the Blueprint for Innovative Healthcare Access program, works with a consortium of public and private partners sharing resources and responsibility, each bringing specific strengths and expertise to address rising Non-Communicable Diseases (NCDs) challenges in underserved communities. Meet the people who are living and breathing the Blueprint in the second episode focusing on the importance of screening of NCDs of a 5-part series of our pilot program in Meru County, Kenya.

Tweet me: Meet the people who are living and breathing @Takeda's Blueprint in the second episode focusing on the importance of screening of NCDs of a 5-part series of our pilot program in Meru County, Kenya. https://bit.ly/3w5qELy

KEYWORDS: takeda, Blueprint for Access to Innovative Healthcare, NYSE: TAK

Recent Quotes

Symbol	Price	Change (%)
GOOG	244.36	-2.82 (-1.14%)

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security. All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.
Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.

Blueprint for Access to Innovative Healthcare Episode 2: Screening

DESCRIPTION:

More News